Company intelligence / Profile preview

DrugStars

Ownership: Private
Development stage: Commercial

Overview

DrugStars operated a mobile app that encouraged patients to take their medications as prescribed by rewarding them with "stars" for each dose taken. These stars could be donated as real money to health charities. The company aimed to improve medication adherence and collect anonymized data on medicine use for research purposes. The business model was based on partnerships with pharmaceutical companies and charities. As of late 2023, the company filed for bankruptcy and ceased operations.

Industry: Digital Health Medical Devices

Partnerships

Various European health charities (e.g., Diabetesforeningen Denmark)Collaborations with pharmaceutical companies for patient insights

Beyond the preview

Go deeper on DrugStars.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DrugStars.

Explore the full profile